Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

BNTX

BioNTech SE ADR

May 10 • 04:00PM ET

91.67

Dollar change -0.39
Percentage change -0.42	%

Healthcare • Biotechnology • Germany • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	191.50	EPS (ttm)	0.48	Insider Own	0.01%	Shs Outstand	237.73M	Perf Week	-1.13%
Market Cap	21.79B	Forward P/E	-	EPS next Y	-2.08	Insider Trans	0.00%	Shs Float	237.71M	Perf Month	5.36%
Income	117.93M	PEG	-	EPS next Q	-2.24	Inst Own	17.77%	Short Float	1.55%	Perf Quarter	-1.58%
Sales	2.95B	P/S	7.39	EPS this Y	-141.49%	Inst Trans	12.40%	Short Ratio	6.12	Perf Half Y	-7.98%
Book/sh	90.72	P/B	1.01	EPS next Y	-21.85%	ROA	0.49%	Short Interest	3.69M	Perf Year	-10.65%
Cash/sh	40.78	P/C	2.25	EPS next 5Y	-	ROE	0.54%	52W Range	85.21 - 125.83	Perf YTD	-13.14%
Dividend Est.	-	P/FCF	3.77	EPS past 5Y	-	ROI	0.54%	52W High	-27.15%	Beta	0.24
Dividend TTM	-	Quick Ratio	11.16	Sales past 5Y	843.27%	Gross Margin	79.32%	52W Low	7.58%	ATR (14)	2.49
Dividend Ex-Date	Jun 02, 2022	Current Ratio	11.38	EPS Y/Y TTM	-98.06%	Oper. Margin	-13.07%	RSI (14)	55.45	Volatility	3.33% 2.51%
Employees	3082	Debt/Eq	0.01	Sales Y/Y TTM	-76.62%	Profit Margin	4.00%	Recom	2.47	Target Price	115.94
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-164.64%	Payout	0.00%	Rel Volume	0.65	Prev Close	92.06
Sales Surprise	-57.48%	EPS Surprise	-6.12%	Sales Q/Q	-85.14%	Earnings	May 06 BMO	Avg Volume	602.89K	Price	91.67
SMA20	3.19%	SMA50	1.33%	SMA200	-8.45%	Trades		Volume	389,844	Change	-0.42%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-23-24	Initiated	BMO Capital Markets	Outperform	$127
Jan-05-24	Initiated	Oppenheimer	Perform
Dec-01-23	Downgrade	JP Morgan	Neutral → Underweight	$106 → $99
Oct-16-23	Downgrade	HSBC Securities	Buy → Hold	$124 → $111
Jul-14-23	Initiated	HSBC Securities	Buy	$124
May-17-23	Upgrade	Redburn	Neutral → Buy	$165 → $170
Dec-15-22	Upgrade	BofA Securities	Neutral → Buy	$239
Aug-17-22	Initiated	Cowen	Market Perform	$177
Jul-13-22	Upgrade	SVB Leerink	Mkt Perform → Outperform
Jul-06-22	Resumed	Canaccord Genuity	Buy	$192
Feb-01-22	Upgrade	Redburn	Sell → Neutral
Dec-16-21	Initiated	Morgan Stanley	Equal-Weight	$294
Nov-10-21	Upgrade	H.C. Wainwright	Neutral → Buy	$360
Oct-22-21	Initiated	Deutsche Bank	Hold	$250
Oct-07-21	Initiated	Jefferies	Hold	$230
Aug-11-21	Upgrade	Bryan Garnier	Neutral → Buy	$451
Jul-19-21	Resumed	Wolfe Research	Outperform	$248
Jun-16-21	Downgrade	Redburn	Neutral → Sell	$146
May-18-21	Initiated	Goldman	Neutral	$173
May-11-21	Downgrade	Bryan Garnier	Buy → Neutral	$135 → $206

Show Previous Ratings

May-07-24 11:26AM	BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript (Insider Monkey)
06:22AM	BioNTech reports net loss of 315.1m in Q1 2024 (Pharmaceutical Technology)
05:08AM	Q1 2024 BioNTech SE Earnings Call (Thomson Reuters StreetEvents)
May-06-24 04:14PM	BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come (Investor's Business Daily)
04:04PM	Analyst Report: BioNTech SE (Morningstar Research)
02:30PM	Loading…
02:30PM	BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript (Motley Fool)
12:11PM	BioNTech Swings to First-Quarter Loss as Lower COVID-19 Commercial Sales Dents Topline (MT Newswires)
12:02PM	What's Going With BioNTech Stock On Monday? (Benzinga)
11:53AM	BNTX Stock Earnings: BioNTech Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
10:16AM	BioNTech Seesaws As Covid Sales Plummet With 90% Of Revenue Still To Come (Investor's Business Daily)
08:57AM	BioNTech Slides After Reporting Losses As Covid Vaccine Sales Take A Hit (Investor's Business Daily)
08:15AM	Sector Update: Health Care (MT Newswires)
07:31AM	BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales (Barrons.com)
07:23AM	BioNTech Swings to Q1 Loss, Revenue Falls -- Shares Decline Pre-Bell (MT Newswires)
07:03AM	UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year (Reuters)
07:03AM	Loading…
07:03AM	BioNTech Slips To Loss In Q1 (RTT News)
06:49AM	BioNTech says 90% of 2024 revenues will accrue at end of year (Reuters)
06:45AM	BioNTech Announces First Quarter 2024 Financial Results and Corporate Update (GlobeNewswire)
May-03-24 10:08AM	Why Earnings Season Could Be Great for BioNTech (BNTX) (Zacks)
Apr-30-24 11:58AM	BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store? (Zacks)
Apr-25-24 01:51PM	Sector Update: Health Care Stocks Drop in Afternoon Trading (MT Newswires)
01:28PM	Wall Street plunges after US inflation shock (The Telegraph)
12:55PM	Update: GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines (MT Newswires)
11:27AM	GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines (MT Newswires)
09:54AM	UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology (Reuters)
09:39AM	GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology (Reuters)
Apr-23-24 07:21AM	Pfizer vs Moderna battle over COVID vaccine patents begins in UK (Reuters)
Apr-22-24 06:08PM	25 Richest Billionaires in Healthcare Industry (Insider Monkey)
06:45AM	BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024 (GlobeNewswire)
Apr-07-24 02:00PM	Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer (GlobeNewswire)
03:39PM	Loading…
Mar-31-24 03:39PM	The 3 Best Bargain Stocks to Buy in Q2 2024 (InvestorPlace)
Mar-26-24 09:53AM	WuXi Biologics Reports Solid 2023 Annual Results (PR Newswire)
06:44AM	3 Biotech Stocks to Buy for the Next Bull Run: March 2024 (InvestorPlace)
01:00AM	This Vaccine Maker Sits on Cash Almost Equal to Its Market Value (Barrons.com)
Mar-25-24 06:47AM	UPDATE 2-BioNTech gets US agency notice over default on COVID vaccine royalties (Reuters)
06:19AM	BioNTech gets notice from NIH on default on royalties (Reuters)
Mar-21-24 11:38AM	BioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcript (Insider Monkey)
01:43AM	Q4 2023 BioNTech SE Earnings Call (Thomson Reuters StreetEvents)
Mar-20-24 04:45PM	BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts (Investor's Business Daily)
03:56PM	Analyst Report: BioNTech SE (Morningstar Research)
03:38PM	BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials (Benzinga)
02:45PM	BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript (Motley Fool)
11:05AM	BioNTech expects more than 10 bln eur peak sales from cancer drug pipeline (Reuters)
10:34AM	BioNTech Earnings Miss Estimates. The Stock Falls and Also Drags Moderna Lower. (Barrons.com)
09:20AM	BioNTech Q4 Net Profit Plummets (RTT News)
09:09AM	BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss Forecasts (Investor's Business Daily)
07:49AM	BioNTech Earnings Fall Short of Estimates. The Stock Is Down. (Barrons.com)
06:22AM	UPDATE 1-After earnings plunge, BioNTech pins hopes on cancer drug launches (Reuters)
06:17AM	BioNTech slides as earnings plunge amid cancer drug shift (Reuters)
06:15AM	BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update (GlobeNewswire)
06:15AM	After earnings plunge, BioNTech pins hopes on cancer drug launches (Reuters)
06:00AM	BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer (GlobeNewswire)
Mar-17-24 09:19AM	Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-15-24 05:53AM	Q4 2023 Autolus Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 01:51PM	Autolus Therapeutics PLC Reports Full Year 2023 Financial Results (GuruFocus.com)
Mar-13-24 11:07AM	Billionaires Biotech Bets: 3 Stocks Dominating Bill Gates Portfolio (InvestorPlace)
Mar-11-24 03:29PM	Moderna, BioNTech Stocks Rise on New mRNA Possibilities (The Wall Street Journal) +5.51%
07:45AM	BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024 (GlobeNewswire)
Mar-09-24 01:09PM	12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-08-24 01:25AM	Here's Why Artisan Mid Cap Fund Harvested BioNTech SE (BNTX) (Insider Monkey)
Mar-07-24 06:45AM	BioNTech Announces Planned Retirement of Sean Marett (GlobeNewswire)
Mar-06-24 04:45PM	3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success (InvestorPlace)
06:45AM	BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024 (GlobeNewswire)
Mar-05-24 04:16AM	Here's Why BioNTech SE (BNTX) Declined 12.2% in Q4 (Insider Monkey)
Mar-04-24 06:42PM	Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound (InvestorPlace)
05:33PM	BioNTech SE investors: Please contact the Portnoy Law Firm to recover your losses; March 12, 2024 deadline (GlobeNewswire)
10:06AM	Its Time! 3 Dodgy Pharma Stocks to Sell in February (InvestorPlace)
Mar-02-24 10:42AM	16 Best Large-Cap Value Stocks To Invest In in 2024 (Insider Monkey)
Feb-27-24 05:45AM	Investors in BioNTech SE Should Contact Levi & Korsinsky Before March 12, 2024 to Discuss Your Rights - BNTX (PR Newswire)
Feb-26-24 12:29PM	Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech Lawsuit BNTX (GlobeNewswire)
10:27AM	BNTX NEWS: Johnson Fistel Encourages BioNTech Investors to Seek Counsel Before the Lead Plaintiff Deadline (GlobeNewswire)
Feb-23-24 01:00PM	BIONTECH SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Feb-14-24 06:35PM	BioNTech SE investors: Please contact the Portnoy Law Firm to recover your losses; March 12, 2024 deadline. (GlobeNewswire)
Feb-08-24 06:07AM	BioNTech partners with Autolus to boost cell therapy manufacturing (BioPharma Dive)
05:45AM	BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs (GlobeNewswire)
Feb-04-24 06:56AM	Five Upcoming Class Actions for Investors to Know About (TipRanks)
Feb-02-24 02:39PM	3 Pharma Stocks to Sell in February Before They Crash and Burn (InvestorPlace)
Feb-01-24 06:30AM	3 Biotech Stock Sensations to Snatch up This Week (Entrepreneur: Stocks)
Jan-31-24 06:45AM	BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305 (GlobeNewswire)
Jan-25-24 09:55AM	Jim Cramer is Recommending These 10 Stocks (Insider Monkey)
Jan-24-24 11:30AM	BIONTECH SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-22-24 06:45AM	BioNTech challenges AstraZeneca with breast cancer precision drug trial (Reuters)
06:45AM	BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer (GlobeNewswire)
Jan-17-24 11:30AM	BIONTECH SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Jan-09-24 04:16PM	Analyst Report: BioNTech SE (Morningstar Research)
07:37AM	BioNTech Issues 2024 Revenue Guidance - Quick Facts (RTT News)
07:12AM	UPDATE 2-BioNTech predicts return to revenue growth in 2025 (Reuters)
07:09AM	Midday movers: Boeing, CrowdStrike and more (Investing.com)
06:52AM	BioNTech predicts return to revenue growth in 2025 (Reuters)
06:45AM	BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
06:45AM	BioNTech expects 2024 revenues of about $3.3 bln (Reuters)
Dec-28-23 12:00AM	This Vaccine Makers Stock Is Worth Owning (Barrons.com)
Dec-24-23 05:34PM	15 Undervalued Defensive Stocks For 2024 (Insider Monkey)
Dec-21-23 08:00AM	BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer (GlobeNewswire)
Dec-19-23 12:31PM	Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today? (Benzinga)
09:12AM	UPDATE 2-German court quashes CureVac patent after challenge by BioNTech (Reuters)
08:35AM	German court quashes CureVac patent after challenge by BioNTech (Reuters)
Dec-18-23 01:15PM	BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda (GlobeNewswire)
10:06AM	BioNTech aims to start mRNA vaccine output in Rwanda in 2025 (Reuters)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTX

BioNTech SE ADR

Upgrade your FINVIZ experience